Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Sarah E Gardner YeltonJames Brewer LeonardCaridad M de la UzRajeev S WadiaSean S BarnesPublished in: Case reports in critical care (2021)
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics and cardioversion, and patients commonly require extracorporeal support. We review the successful resuscitation of two brothers aged 2 and 4 who presented two years apart with unstable wide-complex tachyarrhythmia suspicious for severe flecainide toxicity. Each patient received sodium bicarbonate and 20% intravenous lipid emulsion with a full recovery. While extracorporeal support is often required following flecainide ingestion, we present two cases where it was avoided due to aggressive multimodal management with sodium bicarbonate, electrolyte repletion, and 20% intravenous lipid emulsion. In addition, avoidance of agitation-induced tachycardia may be beneficial.
Keyphrases
- case report
- end stage renal disease
- oxidative stress
- drug induced
- ejection fraction
- high dose
- newly diagnosed
- liver failure
- chronic kidney disease
- atrial fibrillation
- peritoneal dialysis
- fatty acid
- high glucose
- ionic liquid
- catheter ablation
- low dose
- emergency department
- respiratory failure
- hepatitis b virus
- young adults
- adverse drug
- aortic dissection
- fine needle aspiration
- septic shock